Tracheostomy-related data from an intensive care unit for two consecutive years before the COVID-19 pandemic

doi:10.5662/wjm.v14.i2.91868

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (280)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-4) series.

Item

Count

PDF

HTML

199

Tables (1-4)

Sum=233

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=40

Jun 20, 2024 (publication date) through Jul 17, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Methodology

ISSN

2222-0682

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Methodol. Jun 20, 2024; 14(2): 91868
Published online Jun 20, 2024. doi: 10.5662/wjm.v14.i2.91868

Table 3 Comparison between the patients who were subjected to percutaneous tracheostomy and those who were subjected to surgical tracheostomy, n (%)

		Patients with PDT	Patients with ST	P value
Gender	Male	59/96 (61.5)	13/19 (68.4)	0.57
Gender	Female	37/96 (38.5)	6/19 (31.6)	0.57
Age (years)		62.6 ± 14.0	47.6 ± 15.0	< 0.001
Cause of admission	CNS	60/96 (62.5)	5/19 (26.3)	0.004
	CVS	3/96 (3.1)	0/19 (0.0)	1.00
	RS	9/96 (9.4)	2/19 (10.5)	1.00
	Sepsis	3/96 (3.1)	1/19 (5.3)	0.52
	Malignancy	6/96 (6.3)	1/19 (5.3)	1.00
	Trauma	13/96 (13.5)	7/19 (36.8)	0.022
	Surgery	0/96 (0.0)	2/19 (10.5)	0.026
	Metabolic	2/96 (2.1)	1/19 (5.3)	0.42
Cause of intubation	CNS	51/96 (53.1)	3/19 (15.8)	0.003
	CVS	7/96 (7.3)	1/19 (5.3)	1.00
	RS	8/96 (8.3)	2/19 (10.5)	0.67
	Trauma	12/96 (12.5)	4/19 (21.1)	0.30
	Metabolic	6/96 (6.3)	1/19 (5.3)	1.00
	Compromised airway	7/96 (7.3)	6/19 (31.6)	0.008
	Sepsis	5/96 (5.2)	2/19 (10.5)	0.33
	Surgery	0/96 (0.0)	0/19 (0.0)	N/A
GCS (N)		9.2 ± 4.3	11.7 ± 4.2	0.025
APACHE II (N)		19.6 ± 6.4	15.7 ± 7.0	0.020
APDR (%)		35.1 ± 20.3	23.6 ± 16.0	0.022
Number of co-morbidities (N)		1.9 ± 1.5	1.2 ± 1.0	0.044
Co-morbidity	Cardiovascular	52/96 (54.2)	4/19 (21.1)	0.008
	Metabolic	37/96 (38.5)	9/19 (47.4)	0.47
	Respiratory	10/96 (10.4)	3/19 (15.8)	0.45
	Autoimmune	3/96 (3.1)	0/19 (0.0)	1.00
	Malignancy	10/96 (10.4)	0/19 (0.0)	0.21
	Psychiatric	9/96 (9.4)	1/19 (5.3)	1.00
	Renal	6/96 (6.3)	0/19 (0.0)	0.59
	Neurological	8/96 (8.3)	1/19 (5.3)	1.00
	Hematological	3/96 (3.1)	0/19 (0.0)	1.00
	Urological	3/96 (3.1)	0/19 (0.0)	1.00
	Infectious	4/96 (4.2)	0/19 (0.0)	1.00
Reason for tracheostomy	Prolonged mechanical ventilation	22/96 (22.9)	3/19 (15.8)	0.76
	Compromised airway	9/96 (9.4)	7/19 (36.8)	0.005
	Low level of consciousness	45/96 (46.9)	4/19 (21.1)	0.044
	Myopathy	20/96 (20.8)	5/19 (26.3)	0.56
Timing of tracheostomy	Early	53/96 (55.2)	10/19 (52.6)	1.00
Timing of tracheostomy	Late	43/96 (44.8)	9/19 (47.4)	1.00
Reason for early tracheostomy	Prolonged duration of stay	36/53 (67.9)	0/10 (0.0)	< 0.001
	Compromised airway	3/53 (5.7)	5/10 (50.0)	0.002
	Trauma	10/53 (18.9)	3/10 (30.0)	0.42
	Neuromuscular disease	4/53 (7.6)	2/10 (20.0)	0.24
Complications		0/96 (0.0)	0/19 (0.0)	N/A
VAP		25/96 (26.0)	6/19 (31.6)	0.62
Pathogen isolated	None	9/39 (23.1)	2/8 (25.0)	1.00
	Candida albicans	1/39 (2.6)	0/8 (0.0)	1.00
	Klebsiella pneumoniae	3/39 (7.7)	1/8 (12.5)	0.54
	Acinetobacter baumanii	13/39 (33.3)	2/8 (25.0)	1.00
	Pseudomonas aeruginosa	8/39 (20.5)	2/8 (25.0)	1.00
	Staphylococcus aureus	1/39 (2.6)	0/8 (0.0)	1.00
	Proteus mirabilis	1/39 (2.6)	1/8 (12.5)	0.32
	Escherichia coli	1/39 (2.6)	0/8 (0.0)	1.00
	Enterococcus faecium	1/39 (2.6)	0/8 (0.0)	1.00
	Hemophilus influenzae	1/39 (2.6)	0/8 (0.0)	1.00
Days in ICU (N)		22.0 ± 10.9	20.7 ± 9.8	0.64
Transferred to	Ward	65/96 (67.7)	10/19 (52.6)	0.29
	Another hospital	8/96 (8.3)	3/19 (15.8)	0.39
	Rehabilitation center	5/96 (5.2)	2/19 (10.5)	0.33
	CCU	1/96 (1.0)	2/19 (10.5)	0.07
	ICCU	0/96 (0.0)	0/19 (0.0)	N/A
Condition at discharge	T-piece	68/79 (86.1)	14/17 (82.4)	0.71
	Speaking valve	0/79 (0.0)	1/17 (5.9)	0.18
	Tracheostomy closure	5/79 (6.3)	0/17 (0.0)	0.58
	CPAP	0/79 (0.0)	2/17 (11.8)	0.030
	BiPAP	1/79 (1.3)	0/17 (0.0)	1.00
	Pressure ventilator	3/79 (3.8)	0/17 (0.0)	1.00
	Volume ventilator	2/79 (2.5)	0/17 (0.0)	1.00
Breathing at discharge	Unassisted	73/79 (92.4)	15/17 (88.2)	0.63
Breathing at discharge	Assisted	6/79 (7.6)	2/17 (11.8)	0.63
Weaning from mechanical ventilation		70/91 (76.9)	17/19 (89.5)	0.35
Days on mechanical ventilation (N)		18.9 ± 9.7	17.6 ± 10.0	0.60
Survival	Yes	79/96 (82.3)	17/19 (89.5)	0.74
Survival	No	17/96 (17.7)	2/19 (10.5)	0.74

N: Number; CNS: Central nervous system; CVS: Cardiovascular system; RS: Respiratory system; GCS: Glasgow coma scale; APACHE: Acute physiology and chronic health evaluation; APDR: APACHE predicted death rate; VAP: Ventilator associated pneumonia; ICU: Intensive care unit; CCU: Critical care unit; ICCU: Intensive coronary care unit; CPAP: Continuous positive airway pressure; BiPAP: Bi-level positive airway pressure; PDT: Percutaneous dilatation tracheostomy; ST: Surgical tracheostomy.

Citation: Papaioannou M, Vagiana E, Kotoulas SC, Sileli M, Manika K, Tsantos A, Kapravelos N. Tracheostomy-related data from an intensive care unit for two consecutive years before the COVID-19 pandemic. World J Methodol 2024; 14(2): 91868
URL: https://www.wjgnet.com/2222-0682/full/v14/i2/91868.htm
DOI: https://dx.doi.org/10.5662/wjm.v14.i2.91868